308 related articles for article (PubMed ID: 1994527)
1. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
Knight RJ; Kerman RH; Welsh M; Golden D; Schoenberg L; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1991 Feb; 51(2):355-9. PubMed ID: 1994527
[TBL] [Abstract][Full Text] [Related]
2. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
[TBL] [Abstract][Full Text] [Related]
3. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
[TBL] [Abstract][Full Text] [Related]
4. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
Leone MR; Alexander SR; Melvin T; Striegel J; Reller K; Norman DJ; Barry JM
J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
Schulak JA; Mayes JT; Moritz CE; Hricik DE
Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
[TBL] [Abstract][Full Text] [Related]
6. No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience.
Brynger H; Persson H; Flatmark A; Albrechtsen D; Frödin L; Tufvesson G; Gäbel H; Weibull H; Möller E; Lundgren G
Transplant Proc; 1988 Jun; 20(3 Suppl 3):261-3. PubMed ID: 3291253
[No Abstract] [Full Text] [Related]
7. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
9. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
[TBL] [Abstract][Full Text] [Related]
10. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
Martin DC; Tertzakian G; Ruzics E
J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
[TBL] [Abstract][Full Text] [Related]
12. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects of sensitization.
Katznelson S; Bhaduri S; Cecka JM
Clin Transpl; 1997; ():285-96. PubMed ID: 9919412
[TBL] [Abstract][Full Text] [Related]
14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
15. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
[TBL] [Abstract][Full Text] [Related]
16. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
Kandus A; Grego K; Bren AF
Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
[TBL] [Abstract][Full Text] [Related]
17. Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients.
Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
Transplantation; 1987 Jan; 43(1):65-70. PubMed ID: 3541326
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone.
Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O
N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195
[TBL] [Abstract][Full Text] [Related]
19. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M
Nephron; 1997; 75(1):20-4. PubMed ID: 9031265
[TBL] [Abstract][Full Text] [Related]
20. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
Boudreaux JP; McHugh L; Canafax DM; Ascher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
